论文部分内容阅读
目的探讨尿激酶与疏血通联合使用在进展性脑卒中的疗效。方法 82例进展性脑卒中患者随机分为2组,治疗组44例,使用尿激酶50万U+NS100ml静滴,1次/d,连用3d,同时疏血通6ml+NS250ml连用10d。停尿激酶后加用阿司匹林肠溶片200mg,1次/晚,共7d;对照组40例,使用疏血通250ml+NS250ml静脉滴注,1次/d,共10d,同时阿司匹林肠溶片200mg,1次/晚,共10d。结果治疗组治疗有效40例占90.91%;对照组治疗有效29例,占72.5%。结论尿激酶与疏血通联合使用,对进展性脑卒中治疗安全有效,值得临床推广。
Objective To investigate the therapeutic effect of urokinase combined with Shuxuetong in patients with advanced stroke. Methods Eighty-two patients with progressive stroke were randomly divided into two groups. The treatment group consisted of 44 patients. Urokinase 500000U + NS100ml was used intravenously once a day for 3 days. Meanwhile, Shuxuetong 6ml + NS 250ml was used for 10 days. After stopping urokinase plus aspirin enteric-coated tablets 200mg, 1 / night, a total of 7d; control group of 40 patients, the use of Shuxuetong 250ml + NS250ml intravenous infusion, 1 times / d, a total of 10d, aspirin enteric-coated tablets 200mg , 1 time / night, a total of 10d. Results Treatment group 40 cases of effective treatment accounted for 90.91%; control group 29 cases of effective treatment, accounting for 72.5%. Conclusions Urokinase combined with Shuxuetong is safe and effective in the treatment of advanced stroke and is worthy of clinical promotion.